ENTO Financial Statements

Balance sheet, income statement, cash flow, and dividends for First Wave Biopharma Inc (ENTO).


$2.96M Market Cap.

As of 04/01/2025 5:00 PM ET (MRY) • Disclaimer

ENTO Market Cap. (MRY)


ENTO Shares Outstanding (MRY)


ENTO Assets (MRY)


Total Assets

$85.41M

Total Liabilities

$27.61M

Total Investments

$0

ENTO Income (MRY)


Revenue

$0

Net Income

-$18.06M

Operating Expense

$15.62M

ENTO Cash Flow (MRY)


CF Operations

-$9.22M

CF Investing

$88.17K

CF Financing

$5.58M

ENTO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ENTO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$85,409,506 (1140.84%)

$6,883,195 (26.54%)

$5,439,699 (-53.86%)

$11,789,976 (-8.77%)

Assets Current

$83,478,804 (1584.32%)

$4,956,236 (45.23%)

$3,412,755 (-63.79%)

$9,424,952 (19.76%)

Assets Non-Current

$1,930,702 (0.19%)

$1,926,959 (-4.93%)

$2,026,944 (-14.29%)

$2,365,024 (-53.21%)

Goodwill & Intangible Assets

$1,684,182 (0.00%)

$1,684,182 (0.00%)

$1,684,182 (-11.90%)

$1,911,705 (-61.25%)

Shareholders Equity

-$3,876,738 (-207.60%)

$3,602,929 (31.39%)

$2,742,152 (135.06%)

-$7,821,550 (-196.19%)

Property Plant & Equipment Net

$126,753 (-39.64%)

$210,005 (-30.71%)

$303,100 (-25.95%)

$409,307 (342.17%)

Cash & Equivalents

$283,243 (-92.44%)

$3,744,542 (166.98%)

$1,402,572 (-83.09%)

$8,292,696 (36.17%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

-$1,224,135 (-10.03%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$93,014 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,269,829 (162.94%)

$1,623,893 (9.61%)

$1,481,528 (-53.31%)

$3,173,092 (88.25%)

Accumulated Retained Earnings (Deficit)

-$202,388,008 (-9.80%)

-$184,328,672 (-9.37%)

-$168,533,689 (-9.51%)

-$153,904,047 (-61.38%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$140,534 (-83.00%)

$826,844 (-6.43%)

$883,705 (-14.23%)

$1,030,363 (86.52%)

Debt Current

$81,510 (-88.01%)

$679,895 (1.53%)

$669,645 (-6.89%)

$719,225 (30.20%)

Debt Non-Current

$59,024 (-59.83%)

$146,949 (-31.35%)

$214,060 (-31.20%)

$311,138 (0%)

Total Liabilities

$27,605,144 (741.55%)

$3,280,266 (21.60%)

$2,697,547 (-86.25%)

$19,611,526 (26.00%)

Liabilities Current

$27,546,120 (779.14%)

$3,133,317 (26.17%)

$2,483,487 (-79.81%)

$12,300,388 (-20.87%)

Liabilities Non-Current

$59,024 (-59.83%)

$146,949 (-31.35%)

$214,060 (-97.07%)

$7,311,138 (38132.17%)

ENTO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$14,717,333 (37.06%)

$10,737,609 (-10.42%)

$11,986,809 (-34.80%)

$18,384,545 (152.02%)

Research & Development Expense

$903,941 (-82.04%)

$5,033,218 (628.13%)

$691,257 (-98.20%)

$38,320,355 (100.23%)

Operating Expenses

$15,622,652 (-0.94%)

$15,770,827 (24.39%)

$12,678,066 (-78.53%)

$59,056,888 (123.42%)

Interest Expense

-$875 (-103.90%)

$22,463 (41.46%)

$15,879 (41.34%)

$11,235 (-99.81%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$2,440,315 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$18,059,336 (-14.34%)

-$15,794,983 (-7.97%)

-$14,629,642 (75.01%)

-$58,537,849 (-79.17%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$18,059,336 (-14.34%)

-$15,794,983 (-7.97%)

-$14,629,642 (75.01%)

-$58,537,849 (-79.17%)

Preferred Dividends Income Statement Impact

$240,965 (-21.80%)

$308,128 (-10.28%)

$343,427 (-98.68%)

$25,980,739 (186.74%)

Net Income Common Stock

-$18,300,301 (-13.64%)

-$16,103,111 (-7.55%)

-$14,973,069 (82.28%)

-$84,518,588 (-102.53%)

Weighted Average Shares

$3,434,934 (921.26%)

$336,342 (-53.17%)

$718,249 (1589.88%)

$42,503 (213.88%)

Weighted Average Shares Diluted

$3,434,934 (921.26%)

$336,342 (-53.17%)

$718,249 (1589.88%)

$42,503 (213.88%)

Earning Before Interest & Taxes (EBIT)

-$18,060,211 (-14.50%)

-$15,772,520 (-7.93%)

-$14,613,763 (75.03%)

-$58,526,614 (-118.13%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$15,622,652 (0.94%)

-$15,770,827 (-24.39%)

-$12,678,066 (78.53%)

-$59,056,888 (-123.42%)

ENTO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$88,169 (117.63%)

-$500,000 (0%)

$0 (0%)

-$10,319,488 (-11913.95%)

Net Cash Flow from Financing

$5,581,354 (-63.35%)

$15,226,721 (-3.26%)

$15,739,531 (-64.84%)

$44,763,493 (162.60%)

Net Cash Flow from Operations

-$9,217,823 (25.53%)

-$12,377,852 (44.60%)

-$22,344,079 (30.80%)

-$32,288,218 (-187.73%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,548,300 (-251.06%)

$2,348,869 (135.56%)

-$6,604,548 (-406.36%)

$2,155,787 (-63.53%)

Net Cash Flow - Business Acquisitions and Disposals

$88,169 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

-$69,488 (-179.55%)

Issuance (Repayment) of Debt Securities

-$644,582 (-6.81%)

-$603,494 (5.89%)

-$641,236 (-821.86%)

$88,831 (-96.89%)

Issuance (Purchase) of Equity Shares

$6,225,891 (-60.67%)

$15,829,558 (-31.46%)

$23,096,723 (-38.52%)

$37,569,494 (3701.24%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

-$259,713 (-944.43%)

$30,756 (220.20%)

Share Based Compensation

$2,173,550 (91.73%)

$1,133,673 (47.40%)

$769,124 (-43.90%)

$1,371,070 (149.55%)

Depreciation Amortization & Accretion

$48,946 (67.20%)

$29,274 (0.01%)

$29,271 (-94.60%)

$542,255 (-3.25%)

ENTO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-245.70% (60.04%)

-614.80% (-335.74%)

260.80% (105.13%)

-5086.10% (-316.45%)

Return on Average Assets (ROAA)

-21.00% (92.61%)

-284.10% (-8.31%)

-262.30% (56.57%)

-604.00% (-61.71%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-27.70% (-101.71%)

1616.00% (798.28%)

179.90% (-72.83%)

662.20% (6.63%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.12 (-32.95%)

-0.09 (69.86%)

-0.29 (-90.85%)

-0.15 (76.85%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-0.76 (-196.95%)

0.79 (-57.48%)

1.85 (180.41%)

-2.3 (79.39%)

Debt to Equity Ratio (D/E)

-7.12 (-882.53%)

0.91 (-7.52%)

0.98 (139.25%)

-2.51 (57.47%)

Earnings Per Share (EPS)

-5.33 (88.87%)

-47.88 (-128.00%)

-21 (98.94%)

-1,988.53 (35.50%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.68 (92.71%)

-36.8 (-18.30%)

-31.11 (95.91%)

-761.3 (7.41%)

Book Value Per Share (BVPS)

-1.13 (-110.54%)

10.71 (180.57%)

3.82 (102.07%)

-184.02 (5.64%)

Tangible Assets Book Value Per Share (TABVPS)

24.38 (57.69%)

15.46 (195.62%)

5.23 (-97.75%)

232.41 (-60.61%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.14 (-1000.00%)

0.02 (106.37%)

-0.25 (-35.68%)

-0.18 (73.11%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.03 (91.59%)

1.58 (15.14%)

1.37 (79.37%)

0.77 (51.38%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$9,217,823 (25.53%)

-$12,377,852 (44.60%)

-$22,344,079 (30.95%)

-$32,357,706 (-190.62%)

Enterprise Value (EV)

$2,600,116 (1104.64%)

-$258,810 (-107.08%)

$3,657,329 (-65.98%)

$10,751,264 (-40.55%)

Earnings Before Tax (EBT)

-$18,059,336 (-14.34%)

-$15,794,983 (-7.97%)

-$14,629,642 (75.01%)

-$58,537,849 (-79.17%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$18,011,265 (-14.41%)

-$15,743,246 (-7.95%)

-$14,584,492 (74.85%)

-$57,984,359 (-120.72%)

Invested Capital

$56,036,495 (6677.04%)

-$852,002 (-213.12%)

$753,163 (107.78%)

-$9,684,450 (26.03%)

Working Capital

$55,932,684 (2968.30%)

$1,822,919 (96.17%)

$929,268 (132.32%)

-$2,875,436 (62.54%)

Tangible Asset Value

$83,725,324 (1510.41%)

$5,199,013 (38.44%)

$3,755,517 (-61.98%)

$9,878,271 (23.63%)

Market Capitalization

$2,957,007 (4.30%)

$2,834,996 (-44.13%)

$5,074,456 (-71.82%)

$18,005,943 (-38.96%)

Average Equity

$7,448,926 (184.41%)

$2,619,072 (145.61%)

-$5,741,886 (-445.53%)

$1,661,768 (-51.37%)

Average Assets

$87,162,870 (1437.79%)

$5,668,078 (-0.72%)

$5,709,454 (-59.20%)

$13,993,424 (25.24%)

Invested Capital Average

$65,265,001 (6786.63%)

-$976,052 (87.99%)

-$8,125,056 (8.07%)

-$8,838,022 (-104.54%)

Shares

4,754,030 (604.30%)

674,999 (-18.47%)

827,914 (1295.27%)

59,337 (309.73%)